RHRichard D. Head

Richard D. Head

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Richard D. Head has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    SnakeAltPromoter Facilitates Differential Alternative Promoter Analysis

    by Jiang Tan, Yuqing Wu, Ruteja Barve, Jared Lalmansingh, Fuhai Li, Philip Payne, Nahyun Kong, Sheng Chih Jin, Yuqi Shan, Ruiwen Zhou, et al.

    Background: Alternative promoter usage contributes to isoform diversity and gene regulation in mammals but remains difficult to study at scale. Cap Analysis of Gene Expression precisely maps transcription start sites, but its cost limits large-scale application. Alternatively, ProActiv, Salmon, and DEXSeq can be utilized with widely available RNA sequencing (RNA-seq) data to infer promoter activity. However, there is currently no framework available to automate the generation of reproducible results for these methods. Results: SnakeAltPromoter, a scalable end-to-end Snakemake workflow, has been developed to automate alternative promoter analysis from raw RNA-seq data. The workflow performs quality control, alignment, and promoter quantification using 3 complementary RNA-seq analysis methods (junction-based, transcript-based, and first-exon-based), followed by promoter classification and differential activity or usage analysis. SnakeAltPromoter supports both command-line and graphical user interface usage and utilizes standardized modules to enhance reproducibility. A built-in benchmarking module compares promoter activities inferred from RNA-seq data to matched Cap Analysis of Gene Expression data to evaluate quantification performance. Our analyses revealed robust and complementary performance profiles among the evaluated methods across tissues and cell types, highlighting the value of a unified framework for promoter analysis. Conclusions: To our knowledge, SnakeAltPromoter is the first unified and reproducible framework that combines scalable execution and guided method selection for RNA-seq-based promoter analysis. By standardizing and integrating existing RNA-seq-based promoter analysis tools, it provides researchers with a robust and accessible platform to investigate promoter-level regulation and alternative promoter activity and will enhance the research value of large, public RNA-seq repositories. Code is freely available at https://github.com/YidanSunResearchLab/SnakeAltPromoter.git .

  • Open Access

    BRAF mutations may identify a clinically distinct subset of glioblastoma

    by Samantha N. McNulty, Katherine E. Schwetye, Cole Ferguson, Chad E. Storer, George Ansstas, Albert H. Kim, David H. Gutmann, Joshua B. Rubin, Richard D. Head, Sonika Dahiya

    Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. Prior studies examining the mutational landscape of GBM revealed recurrent alterations in genes that regulate the same growth control pathways. To this regard, ~ 40% of GBM harbor EGFR alterations, whereas BRAF variants are rare. Existing data suggests that gain-of-function mutations in these genes are mutually exclusive. This study was designed to explore the clinical, pathological, and molecular differences between EGFR- and BRAF-mutated GBM. We reviewed retrospective clinical data from 89 GBM patients referred for molecular testing between November 2012 and December 2015. Differences in tumor mutational profile, location, histology, and survival outcomes were compared in patients with EGFR- versus BRAF-mutated tumors, and microarray data from The Cancer Genome Atlas was used to assess differential gene expression between the groups. Individuals with BRAF-mutant tumors were typically younger and survived longer relative to those with EGFR-mutant tumors, even in the absence of targeted treatments. BRAF-mutant tumors lacked distinct histomorphology but exhibited unique localization in the brain, typically arising adjacent to the lateral ventricles. Compared to EGFR- and IDH1-mutant tumors, BRAF-mutant tumors showed increased expression of genes related to a trophoblast-like phenotype, specifically HLA-G and pregnancy specific glycoproteins, that have been implicated in invasion and immune evasion. Taken together, these observations suggest a distinct clinical presentation, brain location, and gene expression profile for BRAF-mutant tumors. Pending further study, this may prove useful in the stratification and management of GBM.


  • Open Access

    Rapid and extraction-free detection of SARS-CoV-2 from saliva with colorimetric LAMP

    by Matthew A. Lalli, S. Joshua Langmade, Xuhua Chen, Catrina C. Fronick, Christopher S. Sawyer, Lauren C. Burcea, Michael N. Wilkinson, Robert S. Fulton, Michael Heinz, William J. Buchser, et al.

    Rapid, reliable, and widespread testing is required to curtail the ongoing COVID-19 pandemic. Current gold standard nucleic acid tests are hampered by supply shortages in critical reagents including nasal swabs, RNA extraction kits, personal protective equipment (PPE), instrumentation, and labor. Here we present an approach to overcome these challenges with the development of a rapid colorimetric assay using reverse-transcription loop-mediated isothermal amplification (RT-LAMP) optimized on human saliva samples without an RNA purification step. We describe our optimizations of the LAMP reaction and saliva pretreatment protocols that enabled rapid and sensitive detection of < 10 2 viral genomes per reaction in contrived saliva controls. Moreover, our saliva pretreatment protocol enabled sensitive viral detection by conventional quantitative reverse transcription polymerase chain reaction (qRT-PCR) without RNA extraction. We validated the high performance of these assays on clinical samples and demonstrate a promising approach to overcome the current bottlenecks limiting widespread testing.


  • A multi-amplicon 16S rRNA sequencing and analysis method for improved taxonomic profiling of bacterial communities

    by Andrew E. Schriefer, Paul F. Cliften, Matthew C. Hibberd, Christopher Sawyer, Victoria Brown-Kennerly, Lauren Burcea, Elliott Klotz, Seth D. Crosby, Jeffrey I. Gordon, Richard D. Head